30-Day Notice of Proposed Information Collection: DS 1843 and 1622, Medical History and Examination for Foreign Service, OMB 1405-0068, 15796-15797 [E6-4553]
Download as PDF
15796
Federal Register / Vol. 71, No. 60 / Wednesday, March 29, 2006 / Notices
Extension and Sentencing Commission
Authority Act of 2005, Pub. L. 109–76,
the Commission hereby gives notice of
a temporary, emergency amendment to
the sentencing guidelines, policy
statements, and commentary. This
notice sets forth the temporary,
emergency amendment and the reason
for the amendment.
DATES: The Commission has specified
an effective date of March 27, 2006, for
the emergency amendment set forth in
this notice.
FOR FURTHER INFORMATION CONTACT:
Michael Courlander, Public Affairs
Officer, Telephone: (202) 502–4590.
SUPPLEMENTARY INFORMATION: The
United States Parole Commission
Extension and Sentencing Commission
Authority Act of 2005 requires the
Commission, under emergency
amendment authority, to implement
section 3 of the ASC Act no later than
180 days after the date of enactment of
the United States Parole Commission
Extension and Sentencing Commission
Authority Act of 2005. Accordingly, the
Commission is required to promulgate a
temporary, emergency amendment by
March 27, 2006.
The temporary, emergency
amendment set forth in this notice also
may be accessed through the
Commission’s Web site at https://
www.ussc.gov.
Authority: 28 U.S.C. 994(a), (o), (p), (x);
section 105 of Pub. L. 109–9; and Pub. L.
109–76.
Ricardo H. Hinojosa,
Chair.
1. Amendment: Section 2D1.1 is
amended by redesignating subsections
(b)(6) and (b)(7) as subsections (b)(8)
and (b)(9), respectively; and by inserting
the following after subsection (b)(5):
‘‘(6) If the offense involved the distribution
of an anabolic steroid and a masking agent,
increase by 2 levels.
(7) If the defendant distributed an anabolic
steroid to an athlete, increase by 2 levels.’’.
hsrobinson on PROD1PC68 with NOTICES
Section 2D1.1(c) is amended in the
‘‘*Notes to Drug Quantity Table’’ in
subdivision (F) by striking ‘‘(except
anabolic steroids)’’; and by adding at the
end the following:
‘‘For an anabolic steroid that is not in a
pill, capsule, tablet, or liquid form (e.g.,
patch, topical cream, aerosol), the court shall
determine the base offense level using a
reasonable estimate of the quantity of
anabolic steroid involved in the offense. In
making a reasonable estimate, the court shall
consider that each 25 mg of an anabolic
steroid is one ‘unit’.’’.
Section 2D1.1(c) is amended in the
‘‘*Notes to the Drug Quantity Table’’ by
striking subdivision (G); and by
VerDate Aug<31>2005
15:39 Mar 28, 2006
Jkt 208001
redesignating subdivisions (H) through
(J) as subdivisions (G) through (I),
respectively.
The Commentary to § 2D1.1 captioned
‘‘Application Notes’’ is amended in the
first paragraph of Note 8 by inserting
‘‘Interaction with § 3B1.3.—’’ before ‘‘A
defendant who’’; by striking
‘‘enhancement’’ and inserting
‘‘adjustment’’; and by adding at the end
the following:
‘‘Additionally, an enhancement under
§ 3B1.3 ordinarily would apply in a case in
which the defendant used his or her position
as a coach to influence an athlete to use an
anabolic steroid.’’.
The Commentary to § 2D1.1 captioned
‘‘Application Notes’’ is amended in
Notes 19 and 20 by striking ‘‘(b)(6)’’
each place it appears and inserting
‘‘(b)(8)’’; and in Note 21 by striking
‘‘(b)(7)’’ each place it appears and
inserting ‘‘(b)(9)’’.
The Commentary to § 2D1.1 captioned
‘‘Application Notes’’ is amended by
adding at the end the following:
‘‘24. Application of Subsection (b)(6).—For
purposes of subsection (b)(6), ‘masking agent’
means a substance that, when taken before,
after, or in conjunction with an anabolic
steroid, prevents the detection of the anabolic
steroid in an individual’s body.
25. Application of Subsection (b)(7).—For
purposes of subsection (b)(7), ‘athlete’ means
an individual who participates in an athletic
activity conducted by (i) an intercollegiate
athletic association or interscholastic athletic
association; (ii) a professional athletic
association; or (iii) an amateur athletic
organization.’’.
The Commentary to § 2D1.1 captioned
‘‘Background’’ is amended in the ninth
paragraph by striking ‘‘(b)(6)(A)’’ and
inserting ‘‘(b)(8)(A)’’; and in the last
paragraph by striking ‘‘(b)(6)(B) and (C)’’
and inserting ‘‘(b)(8)(B) and (C)’’.
Reason for Amendment: This
amendment implements the directive in
the United States Parole Commission
Extension and Sentencing Commission
Authority Act of 2005, Pub. L. 109–76,
which required the Commission, under
emergency amendment authority, to
implement section 3 of the Anabolic
Steroid Control Act of 2004, Pub. L.
108–358 (the ‘‘ASC Act’’). The ASC Act
directed the Commission to ‘‘review the
Federal sentencing guidelines with
respect to offenses involving anabolic
steroids’’ and ‘‘consider amending the
* * * guidelines to provide for
increased penalties with respect to
offenses involving anabolic steroids in a
manner that reflects the seriousness of
such offenses and the need to deter
anabolic steroid trafficking and use
* * *.’’
The amendment implements the
directives by increasing the penalties for
PO 00000
Frm 00106
Fmt 4703
Sfmt 4703
offenses involving anabolic steroids. It
does so by changing the manner in
which anabolic steroids are treated
under § 2D1.1 (Unlawful Manufacturing,
Importing, Exporting, or Trafficking
(Including Possession with Intent to
Commit These Offenses); Attempt or
Conspiracy).
The amendment eliminates the
sentencing distinction between anabolic
steroids and other Schedule III
substances when the steroid is in a pill,
capsule, tablet, or liquid form. For
anabolic steroids in other forms (e.g.,
patch, topical cream, aerosol), the
amendment instructs the court that it
shall make a reasonable estimate of the
quantity of anabolic steroid involved in
the offense, and in making such
estimate, the court shall consider that
each 25 mg of anabolic steroid is one
‘‘unit’’.
In addition, the amendment addresses
two harms often associated with
anabolic steroid offenses by providing
new enhancements in § 2D1.1(b)(6) and
(b)(7). Subsection (b)(6) provides a twolevel enhancement if the offense
involved the distribution of an anabolic
steroid and a masking agent. Subsection
(b)(7) provides a two-level enhancement
if the defendant distributed an anabolic
steroid to an athlete. Both
enhancements address congressional
concern with distribution of anabolic
steroids to athletes, particularly the
impact that steroids distribution and
steroids use has on the integrity of sport,
either because of the unfair advantage
gained by the use of steroids or because
of the concealment of such use.
The amendment also amends
Application Note 8 of § 2D1.1 to provide
that an adjustment under § 3B1.3 (Abuse
of Position of Trust or Use of Special
Skill) ordinarily would apply in the case
of a defendant who used his or her
position as a coach to influence an
athlete to use an anabolic steroid.
[FR Doc. 06–3023 Filed 3–28–06; 8:45 am]
BILLING CODE 2211–01–P
DEPARTMENT OF STATE
[Public Notice 5355]
30-Day Notice of Proposed Information
Collection: DS 1843 and 1622, Medical
History and Examination for Foreign
Service, OMB 1405–0068
Notice of request for public
comment and submission to OMB of
proposed collection of information.
ACTION:
SUMMARY: The Department of State has
submitted the following information
collection request to the Office of
E:\FR\FM\29MRN1.SGM
29MRN1
hsrobinson on PROD1PC68 with NOTICES
Federal Register / Vol. 71, No. 60 / Wednesday, March 29, 2006 / Notices
Management and Budget (OMB) for
approval in accordance with the
Paperwork Reduction Act of 1995.
Title of Information Collection:
Medical History and Examination for
Foreign Service.
OMB Control Number: 1405–0068.
Type of Request: Extension of a
Currently Approved Collection.
Originating Office: Office of Medical
Services, M/MED/EX.
Form Number: DS 1843 and DS–1622.
Respondents: Family members of
Foreign Service Officers and Federal
employees stationed abroad.
Estimated Number of Respondents:
9,800.
Estimated Number of Responses:
9,800.
Average Hours Per Response: 1.
Total Estimated Burden: 9,800 hours.
Frequency: Tour of Duty.
Obligation to Respond: Required to
obtain a benefit.
DATES: Comments from the public will
be accepted up to April 28, 2006.
ADDRESSES: Direct comments and
questions to Alex Hunt, the Department
of State Desk Officer in the Office of
Information and Regulatory Affairs at
the Office of Management and Budget
(OMB), who may be reached at 202–
395–7860. You may submit comments
by any of the following methods:
E-mail: ahunt@omb.eop.gov. You
must include the DS form number,
information collection title, and OMB
control number in the subject line of
your message.
Mail (paper, disk, or CD–ROM
submissions): Office of Information and
Regulatory Affairs, Office of
Management and Budget, 725 17th
Street, NW., Washington, DC 20503.
Fax: 202–395–6974.
FOR FURTHER INFORMATION CONTACT: You
may obtain copies of the proposed
information collection and supporting
documents from Susan Willig,
Department of State, Office of Medical
Services, SA–1, Room L101, 2401 E St.,
NW., Washington, DC 20052–0101, who
may be reached on 202–663–1754 or at
willigsp@state.gov.
SUPPLEMENTARY INFORMATION: We are
soliciting public comments to permit
the Department to:
Evaluate whether the proposed
information collection is necessary to
properly perform our functions.
Evaluate the accuracy of our estimate
of the burden of the proposed
collection, including the validity of the
methodology and assumptions used.
Enhance the quality, utility, and
clarity of the information to be
collected.
Minimize the reporting burden on
those who are to respond.
VerDate Aug<31>2005
15:39 Mar 28, 2006
Jkt 208001
Abstract of proposed collection: Form
DS–1843 and DS–1622 are designed to
collect medical information that gives
medical providers the current and
adequate information needed to decide
whether or not a Federal employee, and
family members, will have sufficient
medical resources at a diplomatic
mission abroad.
Methodology: The information will be
collected through the use of an
electronic forms engine, or by hand
written submission using a pre-printed
form.
Dated: March 7, 2006.
Maria C. Melchiorre,
Deputy Executive Director, Office of Medical
Services, Department of State.
[FR Doc. E6–4553 Filed 3–28–06; 8:45 am]
BILLING CODE 4710–36–P
DEPARTMENT OF STATE
[Public Notice 5354]
Bureau of Political-Military Affairs:
Export of Lethal Defense Articles/
Defense Services to Indonesia
Department of State.
Notice.
AGENCY:
ACTION:
SUMMARY: Notice is hereby given that
requests for the export or retransfer of
lethal defense articles to Indonesia (and
defense services related to such lethal
defense articles) pursuant to section 38
of the Arms Export Control Act will be
considered on a case-by-case basis.
DATES: Effective Date: March 29, 2006.
FOR FURTHER INFORMATION CONTACT: Mr.
James Juraska, Office of Defense Trade
Controls Policy, Department of State,
Telephone (202) 663–22860 or Fax (202)
261–8199.
SUPPLEMENTARY INFORMATION: It is the
policy of the U.S. Government, effective
as of March 17, 2006, to consider on a
case-by-case basis applications for the
export of lethal defense articles and
related defense services to Indonesia.
Section 599F(b) of the FY 2006 Foreign
Operations, Export Financing and
Related Programs Appropriations Act
allows for the issuance of licenses for
the export of lethal defense articles for
the Indonesian Armed Forces should
the Secretary of State waive, as being in
the national security interest of the
United States, legislative requirements
for certification of certain conditions
pertaining to Indonesia. Such a waiver
was signed on November 16, 2005. The
Department has also determined that it
shall be U.S. Government policy to
consider on a case-by-case basis
applications for the export of lethal
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
15797
defense articles and related defense
services to Indonesia.
Previously, Federal Register Notices
were published on October 14, 1999 (64
FR 55805), January 25, 2001 (66 FR
7836), and March 22, 2001 (66 FR
16085), that set forth a policy of denial
for new export requests for Indonesia
and suspended all licenses and
approvals to export or otherwise transfer
defense articles and defense services to
Indonesia, except for certain exports
related to commercial communication
satellites and Y2K compliance activities
that were not for the Indonesian
military; permitted review, on a case-bycase basis, of requests for the export of
C–130 spare parts to Indonesia,
including for the Government of
Indonesia; and, expanded the review, on
a case-by-case basis, to defense articles/
defense services exported to Indonesia
for ultimate end-use by a third-country,
respectively.
Further changes to the export policy
toward Indonesia were reflected in a
Federal Register Notice published on
December 18, 2001 (66 FR 65235) that
expanded the categories of defense
articles/defense services eligible for
consideration for export/transfer to
Indonesia, on a case-by-case basis, to
include: (a) Non-lethal defense articles
and spare parts; and (b) non-lethal,
safety-of-use spare parts for lethal enditems. For purposes of that Notice,
‘‘non-lethal defense articles’’ meant an
item not a weapon, ammunition, or
other equipment or material designed to
inflict serious bodily harm or death (see,
e.g., 10 U.S.C. 2557). Examples of safetyof-use items were cartridge actuated
devices, propellant actuated devices,
and technical manuals for military
aircraft for purposes of enhancing the
safety of the aircraft crew. No
distinction was made between
Indonesia’s existing and new inventory.
This Notice expands what may be
authorized for export to Indonesia to
include lethal defense articles
controlled on the U.S. Munitions List, as
well as defense services related to the
export of such lethal defense articles.
Applications for such exports will be
considered on a case-by-case basis in
accordance with standard practice.
This action is taken pursuant to
Sections 38 and 42 of the Arms Export
Control Act (22 U.S.C. 2778, 2791) and
§ 126.7 of the ITAR in furtherance of the
foreign policy of the United States.
Dated: March 22, 2006.
Gregory M. Suchan,
Acting Assistant Secretary, Bureau of Political
Military Affairs, Department of State.
[FR Doc. E6–4555 Filed 3–28–06; 8:45 am]
BILLING CODE 4710–25–P
E:\FR\FM\29MRN1.SGM
29MRN1
Agencies
[Federal Register Volume 71, Number 60 (Wednesday, March 29, 2006)]
[Notices]
[Pages 15796-15797]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-4553]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF STATE
[Public Notice 5355]
30-Day Notice of Proposed Information Collection: DS 1843 and
1622, Medical History and Examination for Foreign Service, OMB 1405-
0068
ACTION: Notice of request for public comment and submission to OMB of
proposed collection of information.
-----------------------------------------------------------------------
SUMMARY: The Department of State has submitted the following
information collection request to the Office of
[[Page 15797]]
Management and Budget (OMB) for approval in accordance with the
Paperwork Reduction Act of 1995.
Title of Information Collection: Medical History and Examination
for Foreign Service.
OMB Control Number: 1405-0068.
Type of Request: Extension of a Currently Approved Collection.
Originating Office: Office of Medical Services, M/MED/EX.
Form Number: DS 1843 and DS-1622.
Respondents: Family members of Foreign Service Officers and Federal
employees stationed abroad.
Estimated Number of Respondents: 9,800.
Estimated Number of Responses: 9,800.
Average Hours Per Response: 1.
Total Estimated Burden: 9,800 hours.
Frequency: Tour of Duty.
Obligation to Respond: Required to obtain a benefit.
DATES: Comments from the public will be accepted up to April 28, 2006.
ADDRESSES: Direct comments and questions to Alex Hunt, the Department
of State Desk Officer in the Office of Information and Regulatory
Affairs at the Office of Management and Budget (OMB), who may be
reached at 202-395-7860. You may submit comments by any of the
following methods:
E-mail: ahunt@omb.eop.gov. You must include the DS form number,
information collection title, and OMB control number in the subject
line of your message.
Mail (paper, disk, or CD-ROM submissions): Office of Information
and Regulatory Affairs, Office of Management and Budget, 725 17th
Street, NW., Washington, DC 20503.
Fax: 202-395-6974.
FOR FURTHER INFORMATION CONTACT: You may obtain copies of the proposed
information collection and supporting documents from Susan Willig,
Department of State, Office of Medical Services, SA-1, Room L101, 2401
E St., NW., Washington, DC 20052-0101, who may be reached on 202-663-
1754 or at willigsp@state.gov.
SUPPLEMENTARY INFORMATION: We are soliciting public comments to permit
the Department to:
Evaluate whether the proposed information collection is necessary
to properly perform our functions.
Evaluate the accuracy of our estimate of the burden of the proposed
collection, including the validity of the methodology and assumptions
used.
Enhance the quality, utility, and clarity of the information to be
collected.
Minimize the reporting burden on those who are to respond.
Abstract of proposed collection: Form DS-1843 and DS-1622 are
designed to collect medical information that gives medical providers
the current and adequate information needed to decide whether or not a
Federal employee, and family members, will have sufficient medical
resources at a diplomatic mission abroad.
Methodology: The information will be collected through the use of
an electronic forms engine, or by hand written submission using a pre-
printed form.
Dated: March 7, 2006.
Maria C. Melchiorre,
Deputy Executive Director, Office of Medical Services, Department of
State.
[FR Doc. E6-4553 Filed 3-28-06; 8:45 am]
BILLING CODE 4710-36-P